Monash University
Browse

Optimising the use of varenicline and smoking cessation interventions in primary and secondary care settings

Download (4.34 MB)
thesis
posted on 2023-02-14, 20:15 authored by RUKSHAR KAIZERALI GOBARANI
Cigarette smoking adversely affects nearly every organ system in the human body. Nicotine replacement therapy, bupropion, and varenicline are three evidence-based pharmacological treatments available to assist smokers in quitting. Of these varenicline is the most effective monotherapy for smoking cessation outcomes. However, absolute cessation rates for varenicline in community-based settings are lower than those observed in clinical trials. This difference may be due to differences in medication adherence rates but it may also suggest the need to evaluate new combinations of existing therapies to further improve quit rates. Thus, the aim of this thesis is to optimise the use of varenicline and smoking cessation interventions in primary and secondary care settings.

History

Campus location

Australia

Principal supervisor

Johnson George

Additional supervisor 1

Michael Abramson

Additional supervisor 2

Billie Bonevski

Year of Award

2023

Department, School or Centre

Centre for Medicine Use and Safety (CMUS)

Course

Doctor of Philosophy

Degree Type

DOCTORATE

Faculty

Faculty of Pharmacy and Pharmaceutical Sciences

Usage metrics

    Faculty of Pharmacy and Pharmaceutical Sciences Theses

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC